LeafNLP Demos
Back to explore

Report #2869850

Received Oct 31, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
TX
Recovered
Unknown
Vaccinated
Oct 3, 2025
Onset
Oct 3, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLULAVAL)GLAXOSMITHKLINE BIOLOGICALSUNK2T543—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

four-month-old patient that was administered a Flulaval vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old female patient who received Flu Seasonal TIV Quebec (FluLaval 2025-2026 season) (batch number 2T543, expiry date 30-JUN-2026) for prophylaxis. On 03-OCT-2025, the patient received FluLaval 2025-2026 season. On 03-OCT-2025, an unknown time after receiving FluLaval 2025-2026 season, the patient experienced inappropriate age at vaccine administration (Verbatim: four-month-old patient that was administered a Flulaval vaccine). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.